Shabir Madhi to Measles Vaccine
This is a "connection" page, showing publications Shabir Madhi has written about Measles Vaccine.
Connection Strength
2,374
-
Immunogenicity and Safety of an Early Measles Vaccination Schedule at 6 and 12 Months of Age in Human Immunodeficiency Virus (HIV)-Unexposed and HIV-Exposed, Uninfected South African Children. J Infect Dis. 2019 09 26; 220(9):1529-1538.
Score: 0,660
-
Measles Immunity at 4.5 Years of Age Following Vaccination at 9 and 15-18 Months of Age Among Human Immunodeficiency Virus (HIV)-infected, HIV-exposed-uninfected, and HIV-unexposed Children. Clin Infect Dis. 2019 08 01; 69(4):687-696.
Score: 0,653
-
Effect of in-utero HIV exposure and antiretroviral treatment strategies on measles susceptibility and immunogenicity of measles vaccine. AIDS. 2013 Jun 19; 27(10):1583-91.
Score: 0,428
-
Impact of nutritional status on vaccine-induced immunity in children living in South Africa: Investigating the B-cell repertoire and metabolic hormones. Vaccine. 2024 May 22; 42(14):3337-3345.
Score: 0,226
-
The unanticipated costs of COVID-19 to South Africa's quadruple disease burden. S Afr Med J. 2020 07 16; 110(8):698-699.
Score: 0,175
-
Maternal HIV infection associated with reduced transplacental transfer of measles antibodies and increased susceptibility to disease. J Clin Virol. 2017 09; 94:50-56.
Score: 0,142
-
Vaccination of the HIV-1 infected child. SADJ. 2001 Dec; 56(12):610-3.
Score: 0,048
-
Measles seroprevalence in pregnant women in Soweto, South Africa: a nested cohort study. Clin Microbiol Infect. 2020 Apr; 26(4):515.e1-515.e4.
Score: 0,042